Skip to main content
Clinical Trials/NCT03892551
NCT03892551
Completed
Not Applicable

Triage - Symptoms and Other Predictors in an All-comer Emergency Department Population (EMERGE IV)

University Hospital, Basel, Switzerland1 site in 1 country7,309 target enrollmentMarch 18, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Triage Risk Stratification
Sponsor
University Hospital, Basel, Switzerland
Enrollment
7309
Locations
1
Primary Endpoint
30-day mortality
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

This study is to develop a tool capable of improved risk prediction regarding the 30-day mortality. Based on vital signs, impaired mobility on presentation (IMOP), Clinical Frailty Scale (CFS) and patients' symptomatology three risk categories (low, intermediate, high risk) will be established.

Detailed Description

Most Emergency Departments (EDs) perform an initial risk stratification of patients, called Triage. Establishing a diagnosis is key for the administration of the appropriate treatment and the following disposition decision. The earlier and the more accurate the final diagnosis is established, the shorter the time to treatment and time to disposition, and thus, the more efficient the patient flow. New ways to improve diagnosis accuracy early on in patients' ED visits are needed. Although a great number of well validated and widely used triage systems exists, to this date no gold standard in triage risk stratification has been established. Most of the existing triage systems rely on the measurement of vital signs and a list of chief complaints. This study is to develop a tool capable of improved risk prediction regarding the 30-day mortality. Based on vital signs, impaired mobility on presentation (IMOP), Clinical Frailty Scale (CFS) and patients' symptomatology three risk categories (low, intermediate, high risk) will be established. According to acuity patients undergo triage or directly proceed to the treatment unit. Patients awaiting triage will be approached by a member of the study personnel and will be verbally informed about the study. Afterwards, patients will be interviewed asking about their symptoms and their reason for presentation. Patients in need of immediate therapy will receive therapy before start of the interview. Following the interview, patients undergo routine triage.The physician performing initial triage will be asked to rate how ill patients appear to be using a numeric scale ranging from 0 (perfect condition) to 10 (extremely ill). Treating physician's will be asked to state their suspected diagnosis as well as differential diagnoses. Follow-up to assess 30-day and 1-year mortality rate and date of death will start one year after the end of the inclusion period.

Registry
clinicaltrials.gov
Start Date
March 18, 2019
End Date
November 30, 2020
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University Hospital, Basel, Switzerland
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • patients presenting to the ED of the University Hospital Basel and awaiting triage

Exclusion Criteria

  • unwillingness to participate
  • insufficient ability to communicate with the study personnel.

Outcomes

Primary Outcomes

30-day mortality

Time Frame: within 30 days of the day of presentation to the ED

30-day mortality is defined as death within 30 days of the day of presentation to the ED

Secondary Outcomes

  • Number of institutionalisations(within 365 days of the day of presentation to the ED)
  • Number of ICU-admissions(day of presentation to the ED)
  • Number of hospitalizations(day of presentation to the ED)
  • Death rate (In-hospital mortality)(from day of presentation to the ED to day of hospital discharge (assessed within 365 days of the day of presentation to the ED))

Study Sites (1)

Loading locations...

Similar Trials